Choroidal Metastases with Exudative Retinal Detachment: Frequency
Exudative retinal detachment is a common and clinically significant complication of choroidal metastases, occurring frequently enough that it should be actively anticipated and managed in these patients.
How Common Is This Association?
While the provided guidelines do not specify an exact percentage, the research evidence demonstrates that exudative retinal detachment is a frequent and well-recognized complication of choroidal metastases:
Historical data from 161 cases showed that the spontaneous course of choroidal metastases "in many cases" leads to irreversible vision loss due to complications including exudative retinal detachment 1
In a modern treatment series of 27 eyes, intravitreal anti-VEGF therapy was administered in 33% of cases specifically to suppress exudative detachments associated with choroidal metastases 2
Multiple case reports consistently document exudative retinal detachment as a presenting or complicating feature of choroidal metastases from diverse primary tumors including choriocarcinoma 3, laryngeal carcinoma 4, bronchial carcinoid 5, endometrial adenocarcinoma 6, lung adenocarcinoma 7, medullary thyroid carcinoma 8, and colon cancer 9
Clinical Context and Recognition
The guidelines characterize choroidal metastases as presenting with "yellow-white elevated choroidal lesions, sometimes multifocal and bilateral" 10. The ACR Appropriateness Criteria explicitly state that exudative retinal detachment can result from "various inflammatory, infectious, neoplastic, vascular, and degenerative conditions" that cause breakdown of the blood-retinal barrier, with choroidal masses being a specific underlying cause to identify 11.
Key Clinical Features to Recognize:
- Presentation: Decreased vision is the most common symptom (74% in one series) 2
- Imaging findings: High internal reflectivity on B-scan ultrasonography distinguishes metastases from other choroidal lesions 10
- Bilateral involvement: One-third of patients develop bilateral choroidal metastases 1
- Posterior pole predilection: 67% of metastatic lesions occur in the posterior pole 1
Clinical Significance
The presence of exudative retinal detachment with choroidal metastases is prognostically important because:
- It indicates active tumor-related vascular permeability and breakdown of the blood-retinal barrier
- Without treatment, it leads to irreversible central vision loss 1
- It requires prompt intervention—early fractionated external beam radiation can prevent vision loss 1
- Modern management includes radiation therapy with or without intravitreal anti-VEGF injections to control both tumor and secondary detachment 2
Treatment Outcomes:
When treated appropriately with radiation ± anti-VEGF therapy, local tumor control with ultrasonographic height regression occurs in essentially all eyes, with reduction of secondary retinal detachments and vision preservation 2.
Diagnostic Approach
When you encounter a choroidal lesion with exudative detachment:
- Obtain detailed oncologic history: 89% of patients with choroidal metastases have a known primary tumor, but 11% present with choroidal metastasis as the first sign of systemic malignancy 1
- Perform B-scan ultrasonography: Look for high internal reflectivity characteristic of metastases 10
- Assess for bilateral involvement: Examine both eyes carefully
- Coordinate systemic evaluation: 60% of patients have additional distant metastases at diagnosis of choroidal involvement 1
The association between choroidal metastases and exudative retinal detachment is common enough that its absence or presence should inform treatment urgency and approach, with the detachment itself serving as both a diagnostic clue and a treatment target.